These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 19361975)

  • 21. The pleasure in context.
    Duff C
    Int J Drug Policy; 2008 Oct; 19(5):384-92. PubMed ID: 17768037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Harm reduction and the global drug control regime: contemporary problems and future prospects.
    Bewley-Taylor DR
    Drug Alcohol Rev; 2004 Dec; 23(4):483-9. PubMed ID: 15763753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dutch drug policy: a model for America?
    Duncan DF; Nicholson T
    J Health Soc Policy; 1997; 8(3):1-15. PubMed ID: 10172982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Developing a sociology of normal substance use.
    Hammersley R
    Int J Drug Policy; 2011 Nov; 22(6):413-4. PubMed ID: 22104588
    [No Abstract]   [Full Text] [Related]  

  • 25. Harm reduction, hepatitis C and opioid pharmacotherapy: an opportunity for integrated hepatitis C virus-specific harm reduction.
    Hallinan R; Byrne A; Dore GJ
    Drug Alcohol Rev; 2007 Jul; 26(4):437-43. PubMed ID: 17564882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using words: the harm reduction conception of drug use and drug users.
    Stafford N
    Int J Drug Policy; 2007 Mar; 18(2):88-91. PubMed ID: 17689350
    [No Abstract]   [Full Text] [Related]  

  • 27. Supply-side harm reduction strategies: Bolivia's experiment with social control.
    Farthing L; Kohl B
    Int J Drug Policy; 2012 Nov; 23(6):488-94. PubMed ID: 22818891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How the harm reduction movement contrasts itself against punitive prohibition.
    Tammi T; Hurme T
    Int J Drug Policy; 2007 Mar; 18(2):84-7. PubMed ID: 17689349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabis policies and user practices: market separation, price, potency, and accessibility in Amsterdam and San Francisco.
    Reinarman C
    Int J Drug Policy; 2009 Jan; 20(1):28-37. PubMed ID: 18367390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
    Kinner SA; Degenhardt L
    Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The size and mix of government spending on illicit drug policy in Australia.
    Moore TJ
    Drug Alcohol Rev; 2008 Jul; 27(4):404-13. PubMed ID: 18584391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of use and harm reduction practices of ecstasy users in Australia.
    Allott K; Redman J
    Drug Alcohol Depend; 2006 Apr; 82(2):168-76. PubMed ID: 16226850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alternative strategies.
    Jones RT
    Ciba Found Symp; 1992; 166():224-32; discussion 232-41. PubMed ID: 1638916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Australian governments' spending on preventing and responding to drug abuse should target the main sources of drug-related harm and the most cost-effective interventions.
    McDonald D
    Drug Alcohol Rev; 2011 Jan; 30(1):96-100. PubMed ID: 21219503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug prohibition and the treatment system: perfect together.
    Magura S
    Subst Use Misuse; 2007; 42(2-3):495-501. PubMed ID: 17558947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. If supply-oriented drug policy is broken, can harm reduction help fix it? Melding disciplines and methods to advance international drug-control policy.
    Greenfield VA; Paoli L
    Int J Drug Policy; 2012 Jan; 23(1):6-15. PubMed ID: 21689918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Economic constraint and modes of consumption of addictive goods.
    Ben Lakhdar C; Bastianic T
    Int J Drug Policy; 2011 Sep; 22(5):360-5. PubMed ID: 21514133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A nested-epidemic model for the spread of hepatitis C among injecting drug users.
    Esposito N; Rossi C
    Math Biosci; 2004; 188():29-45. PubMed ID: 14766092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Harm reduction behaviors among young polysubstance users at raves.
    Fernández-Calderón F; Lozano-Rojas Ó; Rojas-Tejada A; Bilbao-Acedos I; Vidal-Giné C; Vergara-Moragues E; González-Saiz F
    Subst Abus; 2014; 35(1):45-50. PubMed ID: 24588292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are drug detection dogs and mass-media campaigns likely to be effective policy responses to psychostimulant use and related harm? Results from an agent-based simulation model.
    Dray A; Perez P; Moore D; Dietze P; Bammer G; Jenkinson R; Siokou C; Green R; Hudson SL; Maher L
    Int J Drug Policy; 2012 Mar; 23(2):148-53. PubMed ID: 21742481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.